These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 30488476

  • 1. Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies.
    Zhang G, Ma Y, Xi D, Rao Z, Sun X, Wu X.
    Biopharm Drug Dispos; 2019 Jan; 40(1):3-11. PubMed ID: 30488476
    [Abstract] [Full Text] [Related]

  • 2. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
    Nishizawa K, Yoda N, Morokado F, Komori H, Nakanishi T, Tamai I.
    PLoS One; 2019 Jan; 14(4):e0214862. PubMed ID: 30951542
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats.
    Ma YR, Huang J, Shao YY, Ma K, Zhang GQ, Zhou Y, Zhi R, Qin HY, Wu XA.
    Eur J Pharm Sci; 2015 Feb 20; 68():18-26. PubMed ID: 25486332
    [Abstract] [Full Text] [Related]

  • 4. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R, Xu Z, Xu X, Jin J, Zhao Y, Wang T, Li Y, Ma Y.
    Eur J Pharm Sci; 2019 Jan 15; 127():282-290. PubMed ID: 30428337
    [Abstract] [Full Text] [Related]

  • 5. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
    Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K.
    Drug Metab Pharmacokinet; 2005 Oct 15; 20(5):379-86. PubMed ID: 16272756
    [Abstract] [Full Text] [Related]

  • 6. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
    Shi R, Yang Y, Xu Z, Dai Y, Zheng M, Wang T, Li Y, Ma Y.
    Biopharm Drug Dispos; 2018 Jan 15; 39(1):47-58. PubMed ID: 29065218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
    Shibata M, Toyoshima J, Kaneko Y, Oda K, Nishimura T.
    Eur J Clin Pharmacol; 2020 Aug 15; 76(8):1135-1141. PubMed ID: 32472157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F, Pontones CA, Renner B, Mieth M, Hoier E, Auge D, Maas R, Zolk O, Fromm MF.
    Eur J Clin Pharmacol; 2015 Jan 15; 71(1):85-94. PubMed ID: 25552403
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy Increases the Renal Secretion of N1-methylnicotinamide, an Endogenous Probe for Renal Cation Transporters, in Patients Prescribed Metformin.
    Bergagnini-Kolev MC, Hebert MF, Easterling TR, Lin YS.
    Drug Metab Dispos; 2017 Mar 15; 45(3):325-329. PubMed ID: 28069720
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, Sugiyama Y.
    J Pharmacol Exp Ther; 2012 Feb 15; 340(2):393-403. PubMed ID: 22072731
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H, Yamaguchi H, Hidaka K, Ogura J, Kobayashi M, Iseki K.
    J Pharm Sci; 2013 Mar 15; 102(3):1086-94. PubMed ID: 23280877
    [Abstract] [Full Text] [Related]

  • 19. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
    Xiao G, Rowbottom C, Boiselle C, Gan LS.
    Pharm Res; 2018 Jun 18; 35(8):159. PubMed ID: 29915999
    [Abstract] [Full Text] [Related]

  • 20. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
    Matsuzaki T, Morisaki T, Sugimoto W, Yokoo K, Sato D, Nonoguchi H, Tomita K, Terada T, Inui K, Hamada A, Saito H.
    Drug Metab Dispos; 2008 Apr 18; 36(4):649-54. PubMed ID: 18180268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.